Cours suspendu

Gouvernance Gamida Cell Ltd.

GMDA

IL0011552663

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 18:54:51 24/05/2024			Varia. 5j.	Varia. 1 janv.
0,0170 ^USD	+2,41%		-.--%	-

27/05/25	Gamida Cell Ltd. a annulé l'acquisition de bluebird bio, Inc. (NasdaqGS : BLUE) auprès de BlackRock, Inc. (NYSE : BLK), The Vanguard Group, Inc. et d'autres parties.	CI
22/07/24	HOOKIPA Pharma nomme Malte Peters au poste de PDG et Terry Coelho au poste de directeur financier	MT

Comité Exécutif: Gamida Cell Ltd.

Dirigeant

Fonctions occupéesDepuis

Joe Wiley

55 ans

Chief Executive Officer

Ronit Simantov

61 ans

Chief Tech/Sci/R&D Officer

01/07/2017

Yisrael Gewirtz

49 ans

Comptroller/Controller/Auditor

Rory Nealon

58 ans

Chief Operating Officer

24/05/2024

Peter McMahon

Human Resources Officer

Rocio Manghani

Sales & Marketing

01/11/2020

Heayoung Shin

Chief Tech/Sci/R&D Officer

01/06/2021

Composition du Conseil d'Administration: Gamida Cell Ltd.

Administrateur

ComitésDepuis

Joe Wiley

55 ans

Chairman

George Hampton

56 ans

Director/Board Member

01/04/2019

Dernières Nominations: Gamida Cell Ltd.

22/07/24	HOOKIPA Pharma nomme Malte Peters au poste de PDG et Terry Coelho au poste de directeur financier	MT
18/06/24	Gamida Cell nomme Sheila Frame au poste de directeur commercial	CI
18/06/24	Gamida Cell Ltd. nomme Joe Wiley au poste de directeur général	CI
27/03/24	Gamida Cell Ltd. annonce le départ de ses cadres	CI
15/11/23	Gamida Cell Ltd. annonce la démission de M. Jeremy Blank en tant que membre du conseil d'administration	CI
22/05/23	Gamida Cell nomme Terry Coelho au poste de directeur financier	MT
22/05/23	Gamida Cell Ltd. nomme Terry Coelho au poste de directeur financier et de directeur de la comptabilité	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Gamida Cell Ltd.

Insider

Fonctions occupées

DepuisJusqu'au

Stephen Wills

Director/Board Member	01/03/2019	01/06/2024
Independent Dir/Board Member	01/03/2019	01/06/2024

Shawn Tomasello

Director/Board Member	01/06/2019	20/03/2023
Chairman	20/03/2023	24/05/2024
Independent Dir/Board Member	01/06/2019	24/05/2024

Kenneth Moch

Director/Board Member	01/07/2016	24/05/2024
Independent Dir/Board Member	01/07/2016	24/05/2024

Julian Adams

Director/Board Member	18/09/2018	24/05/2024
Chief Executive Officer	20/11/2017	19/09/2022
Chairman	21/11/2016	18/09/2018
Independent Dir/Board Member	18/09/2018	24/05/2024

Ivan Borrello

Director/Board Member	09/06/2022	24/05/2024
Independent Dir/Board Member	09/06/2022	24/05/2024

Abbey Jenkins

Director/Board Member	17/09/2022	24/05/2024
Chief Executive Officer	17/09/2022	24/05/2024
President	17/09/2022	24/05/2024

Joshua Patterson

Compliance Officer	01/08/2021	26/04/2024
General Counsel	01/08/2021	26/04/2024

Michele Korfin

Chief Operating Officer

01/08/2020

01/04/2024

Jeremy Blank

Director/Board Member	11/08/2023	14/11/2023
Independent Dir/Board Member	11/08/2023	14/11/2023

Shai Lankry

Director of Finance/CFO	01/04/2018	22/05/2023
Corporate Officer/Principal	22/05/2023	02/06/2023

Mary Coelho

Comptroller/Controller/Auditor	22/05/2023	-
Director of Finance/CFO	22/05/2023	-

Heather DiVecchia

Human Resources Officer	01/01/2019	-
Investor Relations Contact	01/01/2019	02/04/2023
Public Communications Contact	01/01/2019	02/04/2023

Dorit Jacob

General Counsel

01/08/2015

01/04/2023

Robert Blum

Chairman

18/09/2018

17/03/2023

Naama Halevi-Davidov

Director/Board Member

27/01/2022

16/03/2023

Anat Cohen-Dayag

Director/Board Member

28/01/2022

15/03/2023

Ofer Gonen

Director/Board Member	01/02/2015	09/06/2022
Independent Dir/Board Member	01/02/2015	09/06/2022

Matthew Metivier

Human Resources Officer

01/08/2020

01/01/2022

David Fox

Director/Board Member	01/07/2020	01/11/2021
Independent Dir/Board Member	01/07/2020	01/11/2021

Nurit Benjamini

Director/Board Member	07/01/2019	01/08/2021
Independent Dir/Board Member	07/01/2019	01/08/2021

Tracey Lodie

Chief Tech/Sci/R&D Officer

05/06/2019

01/07/2021

Michael Perry

Director/Board Member	05/06/2017	01/05/2021
Independent Dir/Board Member	05/06/2017	01/05/2021

Tzvi Palash

Chief Operating Officer	01/07/2018	-
Corporate Officer/Principal	-	01/04/2021

Thomas Klima

Corporate Officer/Principal

07/01/2019

01/12/2020

Yona Geffen

Chief Tech/Sci/R&D Officer

01/12/2020

Stephen R. Jamieson

Chief Tech/Sci/R&D Officer

01/10/2020

Jas Uppal

General Counsel

13/01/2020

Roger Kornberg

Director/Board Member

05/06/2017

04/06/2019

Boaz Lifschitz

Director/Board Member	01/11/2014	04/06/2019
Independent Dir/Board Member	01/11/2014	04/06/2019

Paul Nee

Sales & Marketing

01/04/2018

01/01/2019

Yael Margolin

Director/Board Member	01/01/2005	01/01/2019
Chief Executive Officer	01/01/2005	20/11/2017
President	01/01/2005	01/01/2019

Jaren Madden

Investor Relations Contact	01/07/2018	-
Public Communications Contact	01/07/2018	-

Joshua D. Hamermesh

Investor Relations Contact	-	-
Public Communications Contact	-	-
Corporate Officer/Principal	01/04/2018	-

David A. Snyder

Corporate Officer/Principal

01/01/2008

Yaron Daniely

Corporate Officer/Principal

01/01/2003

Hadar Resnekov-Ron

Director/Board Member

14/07/2009

Ruben Krupik

Chairman

14/08/2009

Frederick M. Miesowicz

Corporate Officer/Principal

01/01/2000

Mordechay Kalman Zisser

Director/Board Member

14/07/2009

Dorit Harati

Corporate Officer/Principal

01/08/2000

Naftali Brikashvili

Director of Finance/CFO

01/04/2000

Tony Peled

Chief Tech/Sci/R&D Officer	01/01/1998	-
Founder	01/01/1998	-

Menashe Levy

Founder

01/01/1998

Einat Galamidi

Corporate Officer/Principal

Noam Karstaedt

Director/Board Member

14/07/2009

Ruth Ben-Yakar

Corporate Officer/Principal

14/07/2009

Arye Hasson

Private Equity Analyst

Ehud Marom

President

David A. DeNola

Chief Operating Officer

Ehud Shoshani

Chief Tech/Sci/R&D Officer

Marjie Hadad

Public Communications Contact

Yael Cohen

Corporate Officer/Principal

Frida Grynspan

Chief Tech/Sci/R&D Officer

Michal Austin

General Counsel

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	8
Femme	3

Dont comité exécutif

Homme	5
Femme	2

Dont Administrateurs

Homme	2
Femme	0

Gamida Cell Ltd est une société biopharmaceutique au stade clinique basée en Israël. La société développe des thérapies cellulaires destinées à traiter le cancer et les maladies hématologiques rares et graves. Elle exploite sa technologie d’expansion cellulaire à base de nicotinamide (NAM) pour multiplier divers types de cellules, notamment les cellules souches et les cellules tueuses naturelles (NK), tout en préservant leur phénotype et leur efficacité d’origine. Le portefeuille de produits cliniques de la société comprend : Omidubicel, destiné au traitement des hémopathies malignes et de l'anémie aplasique sévère ; GDA-201, destiné au traitement du lymphome non hodgkinien ; GDA-301, GDA-401 et GDA-501, destinés au traitement des tumeurs solides ; et GDA-601, destiné au traitement du myélome multiple.

Employés

147

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société